Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure

Yuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, Yohei Doi, Keisuke Tomii, Hiroshi Mukae, Naohiko Murata, Ryosuke Imai, Masaki Okamoto, Yasuhiko Yamano, Yasunari Miyazaki, Masahiro Shinoda, Hiromichi Aso, Shinyu Izumi, Haruyuki Ishii, Ryota Ito, Akiko M. Saito, Toshiki I. Saito, Yoshinori Hasegawa

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure'. Together they form a unique fingerprint.

Medicine & Life Sciences